Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01555060 · ClinicalTrials.gov registry record · Phase 2
Hemoglobin and Iron Recovery Study
A Phase 2 study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- Phase 2
- Development phase
- 215
- Enrollment target
NCT01555060 is a Phase 2 study that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 215 participants.
The verdict
NCT01555060, a Phase 2 study, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 215 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effect of daily iron supplements after blood donation on time to recovery of hemoglobin and iron stores. The study will also determine whether the effect of iron supplements on time to recovery is different in men and women, in older vs. younger donors (\<60 years old vs. at least 60 years old) and in donors with replete vs. diminished pre-donation iron stores.
Interventions
- DIETARY_SUPPLEMENT ferrous gluconate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01555060
The ClinicalTrials.gov registry entry for NCT01555060 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 215 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ferrous gluconate is the first listed.
NCT01555060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01555060 about?
NCT01555060 is a clinical study titled "Hemoglobin and Iron Recovery Study". The purpose of this study is to investigate the effect of daily iron supplements after blood donation on time to recovery of hemoglobin and iron stores. The study will also determine whether the effect of iron supplements on time to recovery is different in men and women, in older vs. younger donors...
What is the current status of trial NCT01555060?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 215 participants. The study started on 2012-03. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01555060?
The interventions under investigation include: ferrous gluconate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01555060?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.